1Jackson R T.Mechanism of action of some commonly used nasal drugs.Otolaryngol Head Neck Surg,1991,104:433-440.
2Watanabe H,Face T H,Djazaeri B,et al.Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.Rhinology,2003,41:167-174.
3Salib RJ,Drake-Lee A,Howarth PH.Allergicrhinitis:past,present and the future[J].Clin Otolaryngol,2003,28(4):291.
4The Allergy Report.American Academy of Allergy,Asthma,& ImmunologyTEB/OJ[EB/OL].http://www.theallergyreport.org/reportindex.html,2002.04-02
5Bousquet J,van Cauwenberge P,Khaltaev N,et al.Allergic rhinitis and its impact on asthma[J].Allergy Clin Immunol,2001,108 (5):S147.
6Wood C,Fireman P,Grossman J,et al.Product characteristics and pharmacokinetics of intranasal ipratropium bromide[J].Allergy Clin Immunol,1995,95(5 Pt 2):1111.
7Gentile DA,Friday GA,Jr,Skoner DP.Management of allergic rhinitis:antihistamines and decongestants[J].Immunol Allergy Clin,2000,20(2):355.
8Simpson K,Jarvis B.Fexofenadine:a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria[J].Drugs,2000,59(2):301.
9Day JH,Wllis AK,Rafeiro E.Levocetirizine;a new selective H1 recepter antagonist fou use in allegro disorders[J].Drugs Today(Barc),2004,40(5):415.
10Licberman PL,Settipane RA.Azelastine nasal spray:a review of pharmacology and clinical efficacy inadergic and nonallegic rhinitis[J].Allergy Asthma Proc,2003,24(2):95.
